we monitored 14 asthmatic subjects ( aged 18 to 60 years ) , with multiple 24-hour electrocardiogram ( holter ) recordings , who were taking continuous sustained-release theophylline and beta-2-adrenergic therapy for control of their symptoms .
C0004096
asthmatic
C0039771
theophylline